Early neuropsychological impairment in HIV-seropositive intravenous drug users: Evidence from the Italian multicentre neuropsychological HIV study

Acta Psychiatrica Scandinavica

Volumn 97, Issue 2, 1998, Pages 132-138

  Starace, F ^a   Baldassarre, C ^a   Biancolilli, V ^a   Fea, M ^a   Serpelloni, G ^a   Bartoli, L ^a   Maj, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cognitive impairment; HIV; Neuropsychology; Substance abuse

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; VIRUS INFECTION;

EID: 0031942379     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb09975.x     Document Type: Article

References (31)

1. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe: 1994-1996. Saint-Maurice, France: European Centre for the Epidemiological Monitoring of AIDS, 1996.
2. Ministero della Sanità, Centro Operativo AIDS. Aggiornamento dei casi di AIDS notificati in Italia al 31 settembre 1996 (Update from the Italian AIDS National Register). Rome: Istituto Superiore di Sanità, 1996.
3. GRANT I, ADAMS KM, CARLIN AS et al. Organic impairment in polydrug users: risk factors. Am J Psychiatry 1978: 135: 2-5.
4. ROUNSAVILLE BJ, NOVELLY RA, KELBER HD. Neuropsychological impairment in opiate addicts: risk factors. In: MILLMAN RB, CHUSHMAN P, LOWINSON JH, ed. Research developments in drug and alcohol use. New York: Annals of the New York Academy of Sciences, 1981.
5. STRANG J, GURLING H. Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. Br J Addictions 1989: 84: 1011-1019.
6. CARLIN AS. Neuropsychological consequences of drug abuse. In: GRANT I, ADAMS KM, ed. Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press, 1986: 78-91.
7. HARMAN DE. Neuropsychological toxicology. New York: Pergamon Press, 1988.
8. MALOUF R, JAQUETTE G, DOBKIN J et al. Neurologic disease in human immunodeficiency virus-infected drug abusers. Arch Neurology 1990: 47: 1002-1007.
9. SILBERSTEIN CH, MCKEGNEY FP, O'DOWD MA et al. A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk for HTLV-III/LAV infection in methadone program: preliminary findings. Int J Neurosciences 1987: 32: 669-676.
10. MCKEGNEY FP, O'DOWD MA, FEINER C et al. A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1990: 4: 565-569.
11. TROSS S, PRICE RW, NAVIA B et al. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS 1988: 2: 81-88.
12. EGAN VG, BRETTLE RP, GOODWIN GM. The Edinburgh cohort of HIV-positive drug users: the pattern of cognitive impairment in relation to disease progression. Br J Psychiatry 1992: 161: 522-531.
13. SINFORIANI E, MAURI M, TURLA M et al. Risultati di una valutazione neuropsicologica di soggetti con infezione da HIV in differenti stadi (Neuropsychological evaluation of HIV-seropositive subjects). Giornale Ital AIDS 1991: 2: 157-162.
14. WOODS SW, O'MALLEY SS, MARTINI BL et al. SPECT regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers: preliminary results. Progr Neuro-Psychopharmacol Biol Psychiatry 1991: 15: 649-662.
15. HESTAD K, AUKRUST P, ELLERTSEN B et al. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. J Clin Exp Neuropsychology 1993: 15: 732-742.
16. EGAN VG, CRAWFORD JR, BRETTLE RP et al. The Edinburgh cohort of HIV-positive drug users: current intellectual function is impaired but not due to AIDS dementia complex. J Acquir Imm Def Syndrome 1990: 4: 651-657.
17. ROYAL C, UPDIKE M, SELNES OA et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991: 41: 1905-1911.
18. SELNES OA, MCARTHUR JC, ROYAL W et al. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992: 42: 1924-1930.
19. CONCHA M, GRAHAM NMH, MUNOZ A et al. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol 1992: 136: 1338-1348.
20. MARDER K, STERN Y, MALOUF R et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Arch Neurol 1992: 49: 1169-1175.
21. REZZA G, DE ROSE A, DE ROBERT D, SERAFIN I. Diffusione dell'infezione da HIV nei tossicodipendenti afferenti ai servizi d'assistenza pubblici in Italia: 1990. L'Igiene Moderna 1992: 98: 739-751.
22. MONTGOMERY S, ÅSBERG M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979: 134: 382-389.
23. MAJ M, SATZ P, JANSSEN R et al. WHO Neuropsychiatrie AIDS Study, cross-sectional phase. II. Neuropsychological and neurological findings. Arch Gen Psychiatry 1994: 51: 51-61.
24. WECHSLER D, GREEN RF, MARTINEZ JN. Manual para la escala de inteligencia Wechsler para adultos. Cleveland, OH: The Psychological Corporation, 1968.
25. MAJ M, D'ELIA L, SATZ P et al. Evaluation of three new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1-seropositive persons. A WHO study. Arch Clin Neuropsychology 1993: 8: 123-135.
26. ○ Progetto di Ricerca AIDS. Rome: Istituto Superiore di Sanita, 1994.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
28. INGRAHAM LJ, BRIDGE TP. An empirical approach for determining criteria for change in neuropsychological test batteries. Proceedings of the Conference on Neurological and Neuropsychological Complications of HIV Infection, Monterey, CA, 16-19 June 1990.
29. SATZ P, MORGENSTERN H, MILLER EN et al. Low education as a possible risk factor for early cognitive abnormalities in HIV-1: new findings from the Multicenter AIDS Cohort Study (MACS). J Acquir Immun Defic Syndrome 1993: 6: 503-511.
30. DALLY LG, CHIESI A, TOMINO C et al. HIV independent factors influencing neuropsychological performance in ARC and AIDS individuals. Abstract of the Tenth International Conference on AIDS, Yokohama, Japan, 7-12 August 1994.
31. MAJ M, JANSSEN R, STARACE F et al. WHO Neuropsychiatric AIDS Study, Cross-Sectional Phase. I. Study design and psychiatric findings. Arch Gen Psychiatry 1994: 51: 39-49.